Furthermore, pharmacological inhibition of TG2 on MDA-MB-231 cells using cell-impermeable small molecule inhibitors or antibodies resulted in decreased cell migration [31, 32] and decreased invasiveness [33], which are both hallmarks of cancer [34]. This evidence concerns the gene TGM2 and cancer.